Navigation Links
New Data Presented at AUA's Annual Conference Prove GELNIQUE(TM) (oxybutynin chloride) 10% gel is an Effective, Safe Option for Female Overactive Bladder (OAB) Patients
Date:4/27/2009

- First and Only Topical Gel for OAB to Launch in U.S. Next Month -

CHICAGO, April 27 /PRNewswire-FirstCall/ -- Data to be presented at the American Urological Association's (AUA) Annual Conference show that GELNIQUE(TM) (oxybutynin chloride) 10% gel significantly improves symptoms of OAB and urinary urge incontinence in women with the condition. By the end of the 12-week study period, 27 percent of women treated with GELNIQUE achieved complete urinary continence versus 15.6 percent treated with placebo. There were no treatment-related serious adverse events.

GELNIQUE, the first and only topical gel for the treatment of OAB with symptoms of urge urinary incontinence, urgency, and frequency, is a quick drying, clear and colorless, fragrance-free gel containing oxybutynin hydrochloride that is developed and marketed by Watson Pharmaceuticals, a leader in generic and specialty branded pharmaceuticals. The gel received approval from the U.S. Food and Drug Administration in January 2009 and will launch mid-May.

"Women suffering from OAB often experience severe symptoms at a younger age, so it's important that we have an effective treatment that is both well tolerated and convenient for our female patients," said Roger R. Dmochowski, M.D., professor of urologic surgery at Vanderbilt University Medical Center and director of the Vanderbilt Continence Center, in Nashville, who presented the new findings. "Our new data further confirm that for women with OAB, GELNIQUE is a novel treatment approach with strong efficacy and excellent tolerability."

OAB is characterized by a sudden, uncomfortable need to urinate with or without urge incontinence (urine leakage), and usually includes more frequent urination and nocturia (waking up more than once during the night to urinate). It affects as many as 34 million adults in the U.S. - more than diabetes or asthma. The U.S. OAB market currently
'/>"/>

SOURCE Watson Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine news :

1. NKTR-105 Demonstrates Superior Antitumor Activity and Improved Pharmacokinetics Over Docetaxel in Preclinical Studies Presented at AACR
2. Mersanas Second Development Candidate, XMT-1107, Shows Superior Pharmacokinetics and Anti-Tumor Activity in Studies Presented at American Association of Cancer Research Meeting
3. Altrazeal(TM) Clinical Evidence to be Presented at The American Professional Wound Care Association (APWCA) National Clinical Conference 2009
4. 2009 ESCEO-IOF Alliance for Better Bone Health Young Investigator Award presented to Dr. Nick Harvey
5. IADR Oral Medicine and Pathology Research Award presented to UCLA professor
6. Prizes of the Grand Prix MSOO Award Presented in Moscow
7. Pasadena Marathon Presented By Kaiser Permanente Hails Partnership With Tiffany & Co.
8. Johnson & Johnson to Provide Webcast Presentation of Tapentadol Extended Release (ER) Phase 3 Clinical Data Presented at World Institute of Pain 5th Annual World Congress
9. Destination Fashion 2009 Presented by Stewart Rahr -
10. NovaBay Pharmaceuticals Announces New Preclinical Data to be Presented at the American Academy of Dermatology (AAD) 67th Annual Meeting
11. Crossflo Health Information Exchange Project Presented at HP Health and Life Sciences Symposium
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/2/2015)... 02, 2015 On Wednesday, May 27, 2015, ... to a top speed of 207.9 mph. In the ... to break the 200 mph mark. Jay Leno was ... upcoming episode of Jay Leno’s Garage, which will air on ... the 8.5 mile high speed oval at the Continental Tire ...
(Date:6/2/2015)... UCLA Health and Exer have completed negotiations ... expand urgent care services in Los Angeles County. ... of California Board of Regents and the Exer Board ... to purchase a minority share of four existing Exer ... and Northridge and creates opportunity to grow and develop ...
(Date:6/2/2015)... Prussia, PA (PRWEB) June 02, 2015 ... Outsourcing solutions for health plans in the Medicare Advantage, ... participation as a sponsor and exhibitor at AHIP’s Institute ... America’s Health Insurance Plans. The conference will be held ... exhibition booth, #1303, will offer opportunities for attendees to ...
(Date:6/2/2015)... June 02, 2015 On October 1, ... efforts for another delay. , On Monday, June ... Subcommittee for the House Ways and Means Committee, and ... Centers for Medicare and Medicaid Services, urging the administration ... CMS rolls out ICD-10. ICD-10 is the newest coding ...
(Date:6/2/2015)... (PRWEB) June 02, 2015 IMPAK ... sorbent systems, has announced the availability of “child-resistant” ... of poisons by children, especially curious toddlers. The ... standards and tested to CFR 1700.20 protocols. The ... Cullen. , Looks Like Candy, “With the proliferation ...
Breaking Medicine News(10 mins):Health News:774 HP Hennessey Mustang Tested to 207.9 mph 2Health News:UCLA Health Partners With Exer - More Than Urgent Care 2Health News:TMG Health to Sponsor and Exhibit at AHIP’s Institute 2015 2Health News:HomeTown Health Launches a “100 Day Countdown” in Response to ICD-10 Survey 2Health News:HomeTown Health Launches a “100 Day Countdown” in Response to ICD-10 Survey 3Health News:HomeTown Health Launches a “100 Day Countdown” in Response to ICD-10 Survey 4Health News:IMPAK Introduces Child Resistant Zip Pouches & Bags 2
... MINNEAPOLIS, Dec. 18 MinuteClinic medical clinics in select ... now offering H1N1 vaccinations on demand seven days a ... be obtained at MinuteClinic locations in Maryland in Baltimore ... in North Carolina in Charlotte, Greensboro, Winston-Salem and Raleigh-Durham; ...
... people who have received solid organ transplants and veterinarians should ... That,s just one of the key pieces of advice from ... in the American Journal of Transplantation . ... by members of the American Society of Transplantation,s Infectious Diseases ...
... understanding of TAK1 could lead to new treatments for ... News) -- A protein switch called TAK1 helps prevent ... a team of scientists from the United States and ... improve understanding about the development of liver disease and ...
... , ... Operations to offer enhanced capabilities , ... Milford, NH and Marlboro, MA (PRWEB) December 18, 2009 -- Degree ... electronics and telecommunications industries, announced today that it has sold its IQS Testing business ...
... ... connect with clients and prospective clients, , ... Glendale, CA (Lexis Nexis) December 18, 2009 -- Milton & DeKruif, a Glendale ... it has kicked off an aggressive new client development campaign in order to raise its ...
... ... and create applications on all of their software and hardware platforms -- both new ... ... Systems announced a detailed 2010 product roadmap for NXTware Remote, its Eclipse-based cross-platform ...
Cached Medicine News:Health News:CVS MinuteClinic Now Providing H1N1 Vaccinations On Demand at all Locations in Maryland, North Carolina and Tennessee 2Health News:CVS MinuteClinic Now Providing H1N1 Vaccinations On Demand at all Locations in Maryland, North Carolina and Tennessee 3Health News:Transplant guide highlights daily infection risks from factors like pets and food 2Health News:Transplant guide highlights daily infection risks from factors like pets and food 3Health News:IQS Testing Purchased by The Compliance Management Group 2Health News:IQS Testing Purchased by The Compliance Management Group 3Health News:Milton & DeKruif Launches New Client Development Campaign 2Health News:eCube Announces 2010 NXTware Remote Product Roadmap 2Health News:eCube Announces 2010 NXTware Remote Product Roadmap 3Health News:eCube Announces 2010 NXTware Remote Product Roadmap 4
(Date:6/2/2015)... Research and Markets ( http://www.researchandmarkets.com/research/zkkg9q/blood_processing ) has announced ... - Global Strategic Business Report" report to their offering. ... US, Canada , Japan ... , Latin America , and Rest of ... 2014 through 2020. Also, a seven-year historic analysis is provided ...
(Date:6/2/2015)... 02, 2015 Research and Markets ( http://www.researchandmarkets.com/research/sn8mlw/picture_archiving ) ... Communication Systems (PACS) - Global Strategic Business Report" report ... analytics for the US, Canada , ... Asia-Pacific , Latin America , ... are provided for the period 2014 through 2020. Also, a ...
(Date:6/2/2015)... , June 2, 2015 Today the ... over 150 major food companies, retailers, and human ... Forum on Antibiotic Stewardship. CSTE is committed to ... bacteria, detect resistant strains, preserve the efficacy of ... resistant infections. CSTE continues to serve ...
Breaking Medicine Technology:Blood Processing Supplies and Equipment Market - Global Strategic Business Report 2015-2020 2Blood Processing Supplies and Equipment Market - Global Strategic Business Report 2015-2020 3Picture Archiving and Communication Systems (PACS) - Global Strategic Business Report 2015: User Demand Favors Integrated RIS/PACS Solutions 2
... 2011 Results from a two-year retrospective cohort study ... Academy of Neurology (AAN), Hawaii, U.S., showed that patients ... including hypertension, cardiac dysrhythmias and chronic ischemic heart diseases ... controls without RLS. "These findings suggest ...
... Pharmaceuticals, Inc. (AMEX: AEN ), a developer ... announced today top-line results from its clinical study evaluating ... disease (AD) and mild cognitive impairment (MCI). The clinical ... and decreasing serum free copper. In addition, secondary outcomes ...
Cached Medicine Technology:New Research Links Restless Legs Syndrome (RLS) to Cardiovascular Disease 2New Research Links Restless Legs Syndrome (RLS) to Cardiovascular Disease 3Adeona's Clinical Study of reaZin™ Meets Primary Outcomes of Increasing Serum Zinc and Decreasing Serum Free Copper 2Adeona's Clinical Study of reaZin™ Meets Primary Outcomes of Increasing Serum Zinc and Decreasing Serum Free Copper 3Adeona's Clinical Study of reaZin™ Meets Primary Outcomes of Increasing Serum Zinc and Decreasing Serum Free Copper 4Adeona's Clinical Study of reaZin™ Meets Primary Outcomes of Increasing Serum Zinc and Decreasing Serum Free Copper 5Adeona's Clinical Study of reaZin™ Meets Primary Outcomes of Increasing Serum Zinc and Decreasing Serum Free Copper 6Adeona's Clinical Study of reaZin™ Meets Primary Outcomes of Increasing Serum Zinc and Decreasing Serum Free Copper 7
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
Medicine Products: